Quantitative optimization of reverse transfection conditions for 384-well siRNA library screening

Assay Drug Dev Technol. 2008 Oct;6(5):683-91. doi: 10.1089/adt.2008.142.

Abstract

A necessary step in all small interfering RNA (siRNA) library screens is introduction of the siRNA into cells. We describe the use of a commercially available glyceraldehyde 3-phosphate dehydrogenase enzymatic assay that is capable of simultaneously assessing the efficiency of siRNA delivery into cells and the lipid toxicity. This assay has been modified to work in 384-well plates using reverse transfection. The assay is fast, inexpensive, and quantitative. Conditions identified as optimal using this technique have been employed successfully in library screens.

MeSH terms

  • Base Sequence
  • Cell Count
  • Cell Line, Tumor
  • Data Interpretation, Statistical
  • Gene Library
  • Glyceraldehyde-3-Phosphate Dehydrogenases / genetics
  • Glyceraldehyde-3-Phosphate Dehydrogenases / metabolism
  • Humans
  • Indicators and Reagents
  • Lipids / toxicity
  • RNA, Small Interfering / pharmacology*
  • Reproducibility of Results
  • Reverse Transcriptase Polymerase Chain Reaction
  • Transfection / methods*

Substances

  • Indicators and Reagents
  • Lipids
  • RNA, Small Interfering
  • Glyceraldehyde-3-Phosphate Dehydrogenases